PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: ZOLL Medical Corporation

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference - Seventeen Scientific Presentations Related to ZOLL Technologies Scheduled at ReSS - ZOLL.com
ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference

 

NewswireToday - /newswire/ - Chelmsford, MA, United States, 2016/11/11 - Seventeen Scientific Presentations Related to ZOLL Technologies Scheduled at ReSS - ZOLL.com. NASDAQ: ZOLL

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

ZOLL® Medical Corporation, an Asahi Kasei Group Company that manufactures medical devices and related software solutions, announced today its expanded and fully integrated portfolio of resuscitation and acute critical care technologies and data management solutions will be on display during the American Heart Association (AHA) 2016 Annual Conference in Booth 1639 November 13-15 in New Orleans.

ZOLL is the market leader in hospitals for defibrillators. Its R Series® Monitor/Defibrillator offers continual waveform capnography, which is an American Heart Association (AHA) Class I recommendation for monitoring ET tube placement. It is the only defibrillator to offer both mainstream and sidestream capnography on one device. The R Series utilizes two proprietary technologies to help clinical staff consistently deliver high-quality CPR with minimal pause time, and post-event provides intuitive data management software programs to assist with critical quality improvements.
Unmatched Pediatric Capabilities

ZOLL’s OneStep™ Pediatric CPR Electrodes are used in a majority of the top 25 U.S. News and World Report pediatric cardiology hospitals. These are the only electrodes on the market with a built-in CPR sensor that displays the depth and rate of chest compressions during CPR on young children up to 8 years of age. The first of their kind, these electrodes provide optimal support for pediatric resuscitation when paired with the ZOLL R Series. The OneStep Pediatric CPR Electrodes can be used for monitoring, pacing, and defibrillation, as well as displaying CPR quality on the R Series CPR Dashboard™.
Unsurpassed CPR Support

Increasing the quality of CPR has been an ongoing commitment of ZOLL’s since 2002, when it was the first to introduce real-time CPR feedback in its AED Plus®. Today, all ZOLL defibrillators, including the AED Plus, the AED Pro®, the R Series, and the X Series®, feature Real CPR Help® audio and visual feedback for the correct rate, depth, release, and tracking of idle time. Real CPR Help is the only CPR feedback technology that, in combination with training, has been shown to impact survival to discharge, as demonstrated in published research.1

ZOLL’s commitment to high-quality CPR is also evident in the company’s suite of tools for optimal resuscitation response, which includes See-Thru CPR® as well as EtCO2 monitoring. ZOLL’s proprietary See-Thru CPR technology, which minimizes the duration of pauses in CPR by enabling rescuers to see an organized underlying rhythm, is available on the R Series, the X Series, and the AED Pro.

Additionally, the 2015 AHA Guidelines recommend automated CPR devices, such as the AutoPulse® Resuscitation System, as Class IIb, citing their role in performing high-quality CPR when manual CPR is difficult to achieve, such as during patient transport or in the cath lab.

The 2015 Guidelines expand the recommendation for post-ROSC cooling to include all comatose patients, regardless of rhythm or location of arrest. ZOLL’s Thermogard XP® Temperature Management System is uniquely capable of helping hospitals achieve precise temperature control for any recommended target between 32°C and 36°C.

Also unique to ZOLL is the LifeVest® Wearable Defibrillator, which is worn by patients at risk for sudden cardiac death (SCD), providing protection during their changing condition and while permanent SCD risk has not been established. The LifeVest continuously monitors the patient’s heart and, if a life-threatening heart rhythm is detected, the device delivers a treatment shock to restore normal heart rhythm. The LifeVest is lightweight and easy to wear and allows a patient’s physician time to assess his or her long-term arrhythmic risk and make appropriate plans.

New to ZOLL’s expanding product portfolio is the Eagle II™ portable critical care ventilator, which is used in the management of patients ≥5 kg with acute or chronic respiratory failure. It can be used inside the hospital, during transport, and in MRI suites. The Eagle II is designed to be durable and lightweight, with a 10-hour battery and multiple modes of ventilation, including non-invasive ventilation.
Scientific Assembly Presentations

An education grant from ZOLL helps to underwrite the AHA Resuscitation Science Symposium (ReSS), an international forum for scientists and care providers to discuss recent advances related to treating cardiopulmonary arrest and life-threatening traumatic injury. Seventeen scientific presentations related to ZOLL products and technology are scheduled to be presented during ReSS. Key presentations:

• Liang Wei, BS, will present “Detection of Spontaneous Pulse Using Acceleration Signals Acquired from CPR Feedback Sensor in Porcine Model of Cardiac Arrest,” Saturday, November 12 at 1:47-1:55 pm. in Great Hall C-D. Poster 277.
• Chingping Wan, MD, ZOLL, will present “In-Hospital VT/VF Arrest by Time and Location When Using a Wearable Cardioverter Defibrillator,” Saturday, November 12 at 1:55-2:03 pm. in the Great Hall C-D. Presentation 130.
• Prof. Esteban Lopez de Sá will present “A Pilot Multicenter Randomized Trial on the Effectiveness of Different Levels of Cooling in Comatose Survivors of Out-of-hospital Cardiac Arrest. FROST-I trial,” Saturday, November 12 at 5:15-5:30 pm. Presentation 90.
• Annemarie Silver, PhD, ZOLL, will present “Clinical Feedback from Prehospital Use of a Novel Traumatic Brain Injury Dashboard,” Sunday, November 13 at 8:32-8:40 am. in Great Hall C-D. Poster 277.
• Prof. Dr. Ruth Strasser, University of Dresden, Germany, will present “Original Research Article: Experience with Wearable Defibrillator” during the “Groundbreaking Studies in the Practice of Cardiovascular Medicine: Circulation Editors' Choices” session, Sunday, November 13 at 10:00-10:10 am. in Room 224.
• Yusuke Kondo, MD, PhD, Chiba University Graduate School of Medicine, Japan, will present “Efficacy and Cost-Effectiveness of Wearable Cardioverter Defibrillator as a Lifesaving-Bridge Therapy for Decision in High Risk Patients of Sudden Arrhythmic Death: 3-Year Follow-Up Result,” Sunday, November 13 at 3:45-5:00 pm. in the Science and Technology Hall. Presentation S5260.
• Chengcheng Hu, PhD, will present “Differential Correlation of EtCO2 and CPR Quality between Cardiac and Respiratory Etiology in Out-of-Hospital Cardiac Arrest,” Monday, November 14 at 8:24-8:32 am. in Great Hall C-D. Poster 315.

A listing and schedule of the ZOLL-related presentations is available at zoll.com/aha-presentations2016/.

About ZOLL Medical Corporation
ZOLL Medical Corporation (zoll.com), an Asahi Kasei Group Company, develops and markets medical devices and software solutions that help advance emergency care and save lives, while increasing clinical and operational efficiencies. With products for defibrillation and monitoring, circulation and CPR feedback, data management, therapeutic temperature management, and ventilation, ZOLL provides a comprehensive set of technologies that help clinicians, EMS and fire professionals, and lay rescuers treat victims needing resuscitation and acute critical care.

About Asahi Kasei
The Asahi Kasei Group (asahi-kasei.co.jp) is a diversified group of companies led by holding company Asahi Kasei Corp., with operations in the material, homes, and health care business sectors. Its health care operations include devices and systems for acute critical care, dialysis, therapeutic apheresis, transfusion, and manufacture of biotherapeutics, as well as pharmaceuticals and diagnostic reagents. With more than 30,000 employees around the world, the Asahi Kasei Group serves customers in more than 100 countries.

1. Bobrow BJ, et al. Ann Emerg Med. 2013 Jul;62(1):47 56.e1. Epub 2013 Mar 7.

Copyright © 2016 ZOLL Medical Corporation. All rights reserved. AED Plus, AED Pro, AutoPulse, CPR Dashboard, Eagle II, LifeVest, OneStep, Real CPR Help, R Series, See-Thru CPR, Thermogard XP, X Series, and ZOLL are trademarks or registered trademarks of ZOLL Medical Corporation in the United States and/or other countries. Asahi Kasei is a registered trademark of Asahi Kasei Corporation. All other trademarks are the property of their respective owners.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Medical Services/Equipment Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: ZOLL Medical Corporation

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 
 
  Your Banner Ad showing on ALL
Medical Services/Equipment articles,
CATCH Visitors via Your Competitors Announcements!


ZOLL Technology for Improving CPR Quality to be Showcased at American Heart Association Annual Conference

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Diane Egan - ZOLL.com 
978-421-9637 degan[.]zoll.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any ZOLL Medical Corporation securities in any jurisdiction including any other companies listed or named in this release.

Medical Services/Equipment via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From ZOLL Medical Corporation / Company Profile


Read Medical Services/Equipment Most Recent Related Newswires:

BD Expands Genomics Portfolio with New Single Cell Platform for RNA Expression Analysis
GE Healthcare Advances the Delivery of Cell Therapies with New Thawing Technology
Ansell Limited Announces the Closing of the Sale of its Sexual Wellness Business
PQ Bypass Earns Frost & Sullivan’s European Technology Innovation Award for its Proprietary DETOUR System for Percutaneous Bypass
Curaçao EMS Uses ZOLL Autopulse to Save Tourist in Sudden Cardiac Arrest
ZOLL to Showcase Expanded Portfolio of AEDs at Caravan Salon 2017
MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
Frost & Sullivan Lauds CytoSorbents for Leading the Critical Care Immunotherapy Segment with its Novel Blood Purification Solution, CytoSorb®
MVZ Dr. Stein & Kollegen First German Medical Laboratory to Offer the SelectMDx for Prostate Cancer Test
Datalogic Announces New Healthcare Memor X3 HC Mobile Computer
Neuronix Ltd Announces the First Group of Mild to Moderate Alzheimer Patients to be Successfully Treated by The NeuroAD™ Therapy System
SelectMDx to be Distributed Across Middle East by IPS Genomix
GE Healthcare Partners with Oritain to Introduce Independent Test to Confirm Country of Origin of Fetal Bovine Serum
Saebo, Inc. Awarded Patent for Low-Profile Stroke Recovery Glove
GE Healthcare and HeartFlow Announce Global Cardiovascular Collaboration

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  BizJobs.com

Visit  RightITnow Ltd





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)